FRRS1

gene
On this page

Also known as SDR2

Summary

FRRS1 (ferric chelate reductase 1, HGNC:27622) is a protein-coding gene on chromosome 1p21.2, encoding Ferric reductase 1 (Q6ZNA5). Ferric reductase that reduces Fe(3+) to Fe(2+) and could play a role in iron import into cells.

Members of the cytochrome b561 (CYB561; MIM 600019) family, including FRRS1, reduce ferric to ferrous iron before its transport from the endosome to the cytoplasm (Vargas et al., 2003 [PubMed 14499595]).

Source: NCBI Gene 391059 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 99 total
  • MANE Select transcript: NM_001361041

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27622
Approved symbolFRRS1
Nameferric chelate reductase 1
Location1p21.2
Locus typegene with protein product
StatusApproved
AliasesSDR2
Ensembl geneENSG00000156869
Ensembl biotypeprotein_coding
OMIM611578
Entrez391059

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 3 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000287474, ENST00000370176, ENST00000489209, ENST00000492943, ENST00000646001, ENST00000852116

RefSeq mRNA: 2 — MANE Select: NM_001361041 NM_001013660, NM_001361041

CCDS: CCDS30780, CCDS91007

Canonical transcript exons

ENST00000646001 — 17 exons

ExonStartEnd
ENSE000010287889973808699738268
ENSE000010287909974079399740940
ENSE000010670829971741099717525
ENSE000010670839971953499719647
ENSE000010670899972849399728640
ENSE000011676769974217999742273
ENSE000011676859974729499747430
ENSE000013123969972965099729748
ENSE000017685139974857399748768
ENSE000019744419974889799749001
ENSE000035367129971558699715672
ENSE000035770599971241899712515
ENSE000036057719971210599712163
ENSE000038162199970397099709120
ENSE000038236929976660799766635
ENSE000038287639971080699710949
ENSE000038309699970919899709259

Expression profiles

Bgee: expression breadth ubiquitous, 207 present calls, max score 90.29.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5049 / max 61.8116, expressed in 1230 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
134943.50491230

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233690.29silver quality
liverUBERON:000210788.03gold quality
right lobe of liverUBERON:000111486.43gold quality
germinal epithelium of ovaryUBERON:000130483.27gold quality
adrenal tissueUBERON:001830382.69gold quality
esophagus squamous epitheliumUBERON:000692082.04gold quality
lower esophagus mucosaUBERON:003583482.00gold quality
skin of abdomenUBERON:000141681.66gold quality
colonic epitheliumUBERON:000039781.29gold quality
skin of legUBERON:000151181.21gold quality
esophagus mucosaUBERON:000246981.20gold quality
zone of skinUBERON:000001480.96gold quality
vaginaUBERON:000099679.98gold quality
upper arm skinUBERON:000426379.73silver quality
ectocervixUBERON:001224979.44gold quality
corpus epididymisUBERON:000435979.14gold quality
gingival epitheliumUBERON:000194978.55gold quality
gingivaUBERON:000182878.28gold quality
right adrenal glandUBERON:000123377.55gold quality
stromal cell of endometriumCL:000225577.39gold quality
upper leg skinUBERON:000426276.95gold quality
placentaUBERON:000198776.85gold quality
oral cavityUBERON:000016776.83gold quality
right adrenal gland cortexUBERON:003582776.83gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047376.46gold quality
left adrenal glandUBERON:000123476.07gold quality
uterine cervixUBERON:000000275.98gold quality
mucosa of transverse colonUBERON:000499175.84gold quality
adrenal glandUBERON:000236975.62gold quality
left adrenal gland cortexUBERON:003582575.18gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no6.09
E-MTAB-9801no3.16

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

17 targeting FRRS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-427399.4567.931206
HSA-MIR-1912-3P99.3267.40936
HSA-MIR-1295B-5P99.0367.50810
HSA-MIR-3124-3P98.8768.952123
HSA-MIR-34B-3P98.7067.401171
HSA-MIR-211798.4867.971307
HSA-MIR-34C-3P98.1165.60858
HSA-MIR-5585-5P97.9568.801024
HSA-MIR-365297.7165.431890
HSA-MIR-425397.4865.11692
HSA-MIR-6862-5P97.4864.84713
HSA-MIR-443097.4765.611813
HSA-MIR-3667-5P97.1664.87591
HSA-MIR-4761-3P96.2766.26524
HSA-MIR-450996.1965.80900

Cross-species orthologs

12 orthologs

OrganismSymbolGene ID
danio_reriofrrs1aENSDARG00000076183
danio_reriofrrs1bENSDARG00000077605
mus_musculusFrrs1ENSMUSG00000033386
rattus_norvegicusFrrs1ENSRNOG00000016351
drosophila_melanogasterCG8399FBGN0034067
drosophila_melanogasterCG14515FBGN0039648
drosophila_melanogasterl(2)34FcFBGN0261534
caenorhabditis_elegansWBGENE00007339
caenorhabditis_elegansWBGENE00007545
caenorhabditis_elegansWBGENE00013292
caenorhabditis_elegansWBGENE00019746
caenorhabditis_elegansWBGENE00077490

Paralogs (2): REELD1 (ENSG00000250673), FRRS1L (ENSG00000260230)

Protein

Protein identifiers

Ferric reductase 1Q6ZNA5 (reviewed: Q6ZNA5)

Alternative names: Ferric-chelate reductase 1, Stromal cell-derived receptor 2

All UniProt accessions (1): Q6ZNA5

UniProt curated annotations — full annotation on UniProt →

Function. Ferric reductase that reduces Fe(3+) to Fe(2+) and could play a role in iron import into cells. The electron donor and therefore the reaction mechanism are not known.

Subcellular location. Membrane.

Cofactor. Binds 2 heme b groups non-covalently.

Similarity. Belongs to the FRRS1 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6ZNA5-11yes
Q6ZNA5-22

RefSeq proteins (2): NP_001013682, NP_001347970* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002861Reeler_domDomain
IPR005018DOMON_domainDomain
IPR006593Cyt_b561/ferric_Rdtase_TMDomain
IPR042307Reeler_sfHomologous_superfamily
IPR051237

Pfam: PF02014, PF03351

UniProt features (20 total): transmembrane region 7, binding site 4, domain 3, glycosylation site 3, chain 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZNA5-F188.490.64

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 373 (axial binding residue); 414 (axial binding residue); 446 (axial binding residue); 482 (axial binding residue)

Glycosylation sites (3): 138, 308, 321

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 139 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS, LA_MEN1_TARGETS, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GROSS_HYPOXIA_VIA_HIF1A_UP, GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GOBP_MONOATOMIC_ION_HOMEOSTASIS, BASAKI_YBX1_TARGETS_DN, LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP, chr1p21, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS, CHEN_METABOLIC_SYNDROM_NETWORK

GO Biological Process (1): intracellular iron ion homeostasis (GO:0006879)

GO Molecular Function (3): oxidoreductase activity, acting on metal ions (GO:0016722), metal ion binding (GO:0046872), oxidoreductase activity (GO:0016491)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular monoatomic cation homeostasis1
inorganic ion homeostasis1
oxidoreductase activity1
cation binding1
catalytic activity1
cellular anatomical structure1

Protein interactions and networks

STRING

486 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FRRS1CYB561P49447956
FRRS1HPXP02790774
FRRS1CYB561D2O14569622
FRRS1HSD17B14Q9BPX1507
FRRS1CYBRD1Q53TN4507
FRRS1CYB561A3Q8NBI2478
FRRS1SPDYE2Q495Y8417
FRRS1PALMDQ9NP74412
FRRS1SPATA45Q537H7396
FRRS1OR6K3Q8NGY3396
FRRS1CD109Q6YHK3366
FRRS1SLC11A2P49281358
FRRS1ZNF841Q6ZN19352
FRRS1SLC39A14Q15043348
FRRS1PLPPR4Q7Z2D5323

IntAct

0 interactions, top by confidence:

BioGRID (2): FRRS1 (Proximity Label-MS), FRRS1 (Proximity Label-MS)

ESM2 similar proteins: A0A0G2K1Q8, A2VE04, A4QP81, G5ECB2, O08680, O13146, O62714, O75899, O88871, O88917, O88923, O94910, O95490, O97817, O97827, O97831, P29319, P35384, P48442, P54755, P54757, P54758, Q07497, Q21540, Q5TZ24, Q5U9X3, Q61703, Q62413, Q6INU7, Q6ZNA5, Q7TT41, Q80T41, Q80TR1, Q80TS3, Q8BG22, Q8BXJ9, Q8C7U7, Q8JZZ7, Q8K385, Q8MSU3

Diamond homologs: A0A1B0GV85, A2VE04, P0C963, Q0Q028, Q0Q029, Q5MGQ0, Q6INU7, Q6ZNA5, Q765V4, Q86RS3, Q8K385, Q9V3Y3, A4QP81, B1AXV0, D3ZE85, P35446, P35447, Q8VCC9, Q9GLX9, Q9HCB6, Q9P0K9, Q9W770, Q008X1, O96382, Q8MSU3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

99 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance84
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2891 predictions. Top by Δscore:

VariantEffectΔscore
1:99709193:CTTA:Cdonor_loss1.0000
1:99709195:TA:Tdonor_loss1.0000
1:99709196:ACCTC:Adonor_loss1.0000
1:99709255:TTCAA:Tacceptor_gain1.0000
1:99709256:TCAA:Tacceptor_gain1.0000
1:99709257:CAA:Cacceptor_gain1.0000
1:99709257:CAAC:Cacceptor_gain1.0000
1:99709258:AA:Aacceptor_gain1.0000
1:99709258:AACT:Aacceptor_loss1.0000
1:99709259:ACTG:Aacceptor_loss1.0000
1:99709260:C:CCacceptor_gain1.0000
1:99709260:CT:Cacceptor_loss1.0000
1:99709261:T:Aacceptor_loss1.0000
1:99709264:C:CTacceptor_gain1.0000
1:99710835:T:TAdonor_gain1.0000
1:99710945:TGCCA:Tacceptor_gain1.0000
1:99710947:CCA:Cacceptor_gain1.0000
1:99710948:CA:Cacceptor_gain1.0000
1:99710948:CAC:Cacceptor_gain1.0000
1:99710950:C:CCacceptor_gain1.0000
1:99710954:A:Cacceptor_gain1.0000
1:99710957:C:CTacceptor_gain1.0000
1:99712161:CTT:Cacceptor_gain1.0000
1:99712164:C:CCacceptor_gain1.0000
1:99712168:C:CTacceptor_gain1.0000
1:99712413:AGTAC:Adonor_loss1.0000
1:99712414:GTA:Gdonor_loss1.0000
1:99712415:TA:Tdonor_loss1.0000
1:99712417:C:Adonor_loss1.0000
1:99712514:TG:Tacceptor_gain1.0000

AlphaMissense

3915 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:99710863:A:GW523R0.988
1:99710863:A:TW523R0.988
1:99717488:G:CS386R0.988
1:99717488:G:TS386R0.988
1:99717490:T:GS386R0.988
1:99742259:A:CS116R0.987
1:99742259:A:TS116R0.987
1:99742261:T:GS116R0.987
1:99747345:G:CF94L0.985
1:99747345:G:TF94L0.985
1:99747347:A:GF94L0.985
1:99742182:A:GF142S0.982
1:99747400:A:GF76S0.982
1:99728591:C:GC303S0.981
1:99728592:A:TC303S0.981
1:99747399:A:CF76L0.981
1:99747399:A:TF76L0.981
1:99747401:A:GF76L0.981
1:99728592:A:GC303R0.980
1:99747346:A:GF94S0.979
1:99742217:C:AW130C0.977
1:99742217:C:GW130C0.977
1:99717505:A:GW381R0.976
1:99717505:A:TW381R0.976
1:99740932:A:TV146D0.976
1:99742219:A:GW130R0.976
1:99742219:A:TW130R0.976
1:99747397:A:GL77P0.975
1:99717464:G:CF394L0.974
1:99717464:G:TF394L0.974

dbSNP variants (sampled 300 via entrez): RS1000008487 (1:99704658 G>A), RS1000050906 (1:99743115 T>A,C), RS1000095837 (1:99706668 T>G), RS1000106892 (1:99749524 T>C), RS1000130434 (1:99752609 T>C), RS1000151011 (1:99712339 T>C), RS1000152920 (1:99756700 A>G), RS1000207488 (1:99747165 T>C), RS1000210455 (1:99704974 G>A), RS1000221461 (1:99712823 G>A), RS1000359510 (1:99704842 G>C), RS1000403168 (1:99737804 A>G), RS1000469025 (1:99719096 G>A,C), RS1000553735 (1:99711232 T>A,C), RS1000566131 (1:99732601 T>C,G)

Disease associations

OMIM: gene MIM:611578 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST001764_6White matter integrity (bipolar disorder risk interaction)9.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004641white matter integrity

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Idecreases expression1
dicrotophosdecreases expression1
propionaldehydeincreases expression1
bisphenol Adecreases methylation1
ethyl-p-hydroxybenzoateincreases expression1
sodium arseniteincreases expression1
potassium chromate(VI)increases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideincreases expression1
jinfukangdecreases expression1
Fulvestrantincreases methylation1
Air Pollutantsincreases abundance, increases expression1
Estradiolaffects cotreatment, decreases expression1
Naledaffects expression1
Silicon Dioxidedecreases expression1
Tretinoinincreases expression1
Cyclosporinedecreases methylation1
Antirheumatic Agentsdecreases expression1
Okadaic Aciddecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.